LEVAQUIN

Product NDC
67296-0372
11-digit product format
672960372
Labeler code
67296
Product ID
67296-0372_9ee3191e-6836-4324-892c-1ccd55baf473
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
levofloxacin
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
RedPharm Drug Inc.
Application
NDA020634
Marketing category
NDA
Marketing start
1996-12-20
Marketing end
0000-00-00
Substance
LEVOFLOXACIN
Active strength
500 mg/1
Pharmacologic classes
Quinolone Antimicrobial [EPC],Quinolones [CS]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
addb5519-f7ae-4d4e-b9ca-f782a1597fd3Product name220210610
fb758c6a-fdee-40a8-99c2-46f79c3ff90cProduct name420200807
1a81e9a9-11c3-4fcf-b5dd-f6798fef8e6dProduct name120190618
aea4a616-4dfe-45f6-94bb-8b9063056cebProduct name620190611
2246ce8e-a477-4dc3-b6d6-fe9973c18ed1Product name120180821
5a6c788d-375b-4565-a8ae-67c179a30c93Product name120180212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
67296-0372-12019-10-29C16284748780-1960f7f55-d29e-8e05-e053-dbdaa90a074aThese highlights do not include all the information needed to use LEVAQUIN ® safely and effectively. See full prescribing information for LEVAQUIN. LEVAQUIN ® (levofloxacin) Tablet, Film Coated for Oral use LEVAQUIN ® (levofloxacin) Solution for Oral use LEVAQUIN ® (levofloxacin) Injection, Solution, Concentrate for Intravenous use LEVAQUIN ® (levofloxacin) Injection, Solution for Intravenous use Initial U.S. Approval: 1996
67296-0372-22019-10-29C16284748780-1960f7f55-d29e-8e05-e053-dbdaa90a074aThese highlights do not include all the information needed to use LEVAQUIN ® safely and effectively. See full prescribing information for LEVAQUIN. LEVAQUIN ® (levofloxacin) Tablet, Film Coated for Oral use LEVAQUIN ® (levofloxacin) Solution for Oral use LEVAQUIN ® (levofloxacin) Injection, Solution, Concentrate for Intravenous use LEVAQUIN ® (levofloxacin) Injection, Solution for Intravenous use Initial U.S. Approval: 1996
67296-0372-32019-10-29C16284748780-1960f7f55-d29e-8e05-e053-dbdaa90a074aThese highlights do not include all the information needed to use LEVAQUIN ® safely and effectively. See full prescribing information for LEVAQUIN. LEVAQUIN ® (levofloxacin) Tablet, Film Coated for Oral use LEVAQUIN ® (levofloxacin) Solution for Oral use LEVAQUIN ® (levofloxacin) Injection, Solution, Concentrate for Intravenous use LEVAQUIN ® (levofloxacin) Injection, Solution for Intravenous use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67296-0372-1LEVAQUIN10 in 1 BOTTLETABLET, FILM COATED102
67296-0372-2LEVAQUIN7 in 1 BOTTLETABLET, FILM COATED72
67296-0372-3LEVAQUIN5 in 1 BOTTLETABLET, FILM COATED52

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67296-0372LEVAQUIN (LEVOFLOXACIN) TABLET, FILM COATED [REDPHARM DRUG INC.]2Legacy NDC, 3 package rows20110729_40a96527-f89e-4177-9224-5c79167f3e60.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
211816LEVAQUIN 500 MG Oral TabletPSN40a96527-f89e-4177-9224-5c79167f3e602
199885levoFLOXacin 500 MG Oral TabletPSN40a96527-f89e-4177-9224-5c79167f3e602
211816levofloxacin 500 MG Oral Tablet [Levaquin]SBD40a96527-f89e-4177-9224-5c79167f3e602
199885levofloxacin 500 MG Oral TabletSCD40a96527-f89e-4177-9224-5c79167f3e602
211816Levaquin 500 MG Oral TabletSY40a96527-f89e-4177-9224-5c79167f3e602

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
67296-0372-16729603720110 in 1 BOTTLEHistorical
67296-0372-2672960372027 in 1 BOTTLEHistorical
67296-0372-3672960372035 in 1 BOTTLEHistorical